amiodarone has been researched along with Myocarditis in 15 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We previously showed that amiodarone, an iodine-rich benzofuranic derivative, interferes with the progression of myocarditis using a rat model of experimental autoimmune myocarditis." | 7.74 | Involvement of thymus in amiodarone-treated autoimmune myocarditis in rats. ( Fu, ML; Han, JF; Katsuda, S; Matsui, S; Zong, ZP, 2008) |
| "Eleven critically ill patients with life-threatening cardiac arrhythmias refractory to currently approved antiarrhythmic drugs were treated with intravenous amiodarone." | 7.67 | Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient. ( Leak, D, 1986) |
| "We previously showed that amiodarone, an iodine-rich benzofuranic derivative, interferes with the progression of myocarditis using a rat model of experimental autoimmune myocarditis." | 3.74 | Involvement of thymus in amiodarone-treated autoimmune myocarditis in rats. ( Fu, ML; Han, JF; Katsuda, S; Matsui, S; Zong, ZP, 2008) |
| "Eleven critically ill patients with life-threatening cardiac arrhythmias refractory to currently approved antiarrhythmic drugs were treated with intravenous amiodarone." | 3.67 | Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient. ( Leak, D, 1986) |
| "Amiodarone is an effective and widely used antiarrhythmic drug with many possible adverse effects including hypercholesterolaemia and hepatotoxicity." | 1.48 | Desmosterol accumulation in users of amiodarone. ( Gylling, H; Kupari, M; Lampi, AM; Lehtonen, J; Piironen, V; Simonen, P; Stenman, UH, 2018) |
| "Giant cell myocarditis is a rare but often devastating disease affecting young, otherwise healthy individuals." | 1.37 | Giant cell myocarditis: an unusual presentation. ( Ali, D; Alzuwam, A; Been, M; McCann, GP; Osman, F, 2011) |
| "Giant cell myocarditis is a rare and highly lethal disease that is characterized by a rapidly progressive course of biventricular dysfunction." | 1.37 | Incessant ventricular tachycardia and cardiogenic shock: a common presentation of an uncommon diagnosis. ( Drafts, BC; Dubose, TD; Sutton, BJ; Thohan, V, 2011) |
| "The combination of ventricular tachycardia (VT) and severe left ventricular dysfunction presents a serious challenge in management of acute fulminant myocarditis (AFM)." | 1.35 | Ventricular tachycardia in acute fulminant myocarditis: medical management and follow-up. ( Acharya, S; Flood, V; Rao, SP; Sathanandam, S; Sharma, JR, 2008) |
| "Amiodarone treatment improved left ventricular pressure, central venous pressure, and rate of isovolumetric contraction and decreased ventricular weight (P<0." | 1.33 | Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy. ( Aizawa, Y; Hanawa, H; Hirono, S; Ito, M; Kashimura, T; Kato, K; Kodama, M; Ma, M; Okura, Y; Tachikawa, H; Takahashi, T; Watanabe, K, 2005) |
| "In the patients with a left bundle branch block morphology of VT (7 cases), four showed findings compatible with an arrhythmogenic right ventricular dysplasia or a right ventricular cardiomyopathy." | 1.27 | Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic haemodynamic and histologic study. ( Alberti, E; Camerini, F; Morgera, T; Salvi, A; Silvestri, F, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simonen, P | 1 |
| Lehtonen, J | 2 |
| Lampi, AM | 1 |
| Piironen, V | 1 |
| Stenman, UH | 1 |
| Kupari, M | 2 |
| Gylling, H | 1 |
| Wang, FY | 1 |
| Zhao, DY | 1 |
| Zhou, JQ | 1 |
| Ekström, K | 1 |
| Kandolin, R | 1 |
| Räisänen-Sokolowski, A | 1 |
| Salmenkivi, K | 1 |
| Ross, JJ | 1 |
| Britton, KA | 1 |
| Desai, AS | 1 |
| Stevenson, WG | 1 |
| Ali, D | 1 |
| Alzuwam, A | 1 |
| McCann, GP | 1 |
| Been, M | 1 |
| Osman, F | 1 |
| Drafts, BC | 1 |
| Sutton, BJ | 1 |
| Dubose, TD | 1 |
| Thohan, V | 1 |
| Matsui, S | 2 |
| Zong, ZP | 2 |
| Han, JF | 2 |
| Katsuda, S | 2 |
| Yamaguchi, N | 1 |
| Fu, ML | 2 |
| Tachikawa, H | 1 |
| Kodama, M | 1 |
| Watanabe, K | 1 |
| Takahashi, T | 1 |
| Ma, M | 1 |
| Kashimura, T | 1 |
| Ito, M | 1 |
| Hirono, S | 1 |
| Okura, Y | 1 |
| Kato, K | 1 |
| Hanawa, H | 1 |
| Aizawa, Y | 1 |
| Riera, M | 1 |
| Herrero, J | 1 |
| Antón, E | 1 |
| Fiol, M | 1 |
| Sharma, JR | 1 |
| Sathanandam, S | 1 |
| Rao, SP | 1 |
| Acharya, S | 1 |
| Flood, V | 1 |
| Ito, H | 1 |
| Ono, K | 1 |
| Nishio, R | 1 |
| Sasayama, S | 1 |
| Matsumori, A | 1 |
| Rogers, JG | 1 |
| Windle, JR | 1 |
| McManus, BM | 1 |
| Easley, AR | 1 |
| Leak, D | 1 |
| Morgera, T | 1 |
| Salvi, A | 1 |
| Alberti, E | 1 |
| Silvestri, F | 1 |
| Camerini, F | 1 |
15 other studies available for amiodarone and Myocarditis
| Article | Year |
|---|---|
Desmosterol accumulation in users of amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Biopsy; Cardiac Imaging Techniques; Cardiomyopathies; Cholestero | 2018 |
[Treatment of ventricular flutter associated with fulminant myocarditis by electrical defibrillation combined with amiodarone in a child].
Topics: Amiodarone; Combined Modality Therapy; Electric Countershock; Humans; Infant; Male; Myocarditis; Ven | 2013 |
Long-term outcome and its predictors in giant cell myocarditis.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhy | 2016 |
Interactive medical case. The beat goes on.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Bundle-Branch Block; Cardiomyopathy, Dilated; Def | 2010 |
Giant cell myocarditis: an unusual presentation.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Cardiac Resynchronization T | 2011 |
Incessant ventricular tachycardia and cardiogenic shock: a common presentation of an uncommon diagnosis.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Blood Chemical Analysis; Cardiac Catheterization; | 2011 |
Amiodarone minimizes experimental autoimmune myocarditis in rats.
Topics: Amiodarone; Animals; Autoimmune Diseases; Cell Line; Male; Myocarditis; Rats; Rats, Inbred Lew | 2003 |
Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Amiodarone; Animals; Blood Pressure; Cardiomyopathy, Dilated; Cytokines; Dise | 2005 |
[Myocarditis and arrhythmogenic dysplasia of right ventricle].
Topics: Aged; Amiodarone; Arrhythmogenic Right Ventricular Dysplasia; Bundle-Branch Block; Cardiac Pacing, A | 2006 |
Involvement of thymus in amiodarone-treated autoimmune myocarditis in rats.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; CD8-Positive T-Lym | 2008 |
Ventricular tachycardia in acute fulminant myocarditis: medical management and follow-up.
Topics: Acute Disease; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Drug Th | 2008 |
Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice.
Topics: Amiodarone; Animals; Cardiovirus Infections; Cytokines; Disease Models, Animal; Encephalomyocarditis | 2002 |
Aspergillus myocarditis presenting as myocardial infarction with complete heart block.
Topics: Aged; Amiodarone; Aspergillosis; Aspergillus flavus; Heart; Heart Block; Humans; Lung Diseases; Male | 1990 |
Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Dopamine; Electrocardiog | 1986 |
Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic haemodynamic and histologic study.
Topics: Adult; Aged; Amiodarone; Biopsy; Bundle-Branch Block; Cardiomyopathies; Drug Therapy, Combination; E | 1985 |